Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1

Status

Completed 6Unknown 4Terminated 4Withdrawn 2Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 4Recurrence 1Neoplastic Cells, Circulating 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Chemoembolization, Therapeutic × Clear all
NCT01393093 2017-06-12

TACE-KMG

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
2,840 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02631499 2015-12-22

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Fudan University

Phase 4 Unknown
256 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Recurrence

NCT01393197 2015-12-18

TACE-KMG

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
2,480 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡